Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
Molecular Diagnostics (MDL)
MD Anderson Departments
Translational Molecular Pathology
Overview
Fingerprint
Research output
(16)
Fingerprint
Dive into the research topics where Molecular Diagnostics (MDL) is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Pancreatic Neoplasms
Medicine & Life Sciences
100%
Allelic Imbalance
Medicine & Life Sciences
87%
Neoplasms
Medicine & Life Sciences
70%
Adenocarcinoma
Medicine & Life Sciences
70%
Traumatic Brain Injury
Medicine & Life Sciences
51%
Mutation
Medicine & Life Sciences
40%
Circulating Tumor DNA
Medicine & Life Sciences
37%
Sequencing
Mathematics
37%
Research output
Research output per year
2018
2018
2019
2019
14
Article
1
Chapter
1
Letter
Research output per year
Research output per year
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
Bernard, V., Kim, D. U.,
San Lucas, F. A.
, Castillo, J., Allenson, K., Mulu, F. C., Stephens, B. M., Huang, J., Semaan, A.,
Guerrero, P. A.
, Kamyabi, N., Zhao, J., Hurd, M. W.,
Koay, E. J.
, Taniguchi, C. M., Herman, J. M.,
Javle, M.
,
Wolff, R.
,
Katz, M.
, Varadhachary, G.,
& 2 others
Maitra, A.
&
Alvarez, H. A.
,
Jan 2019
,
In:
Gastroenterology.
156
,
1
,
p. 108-118.e4
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
Circulating Tumor DNA
100%
Cell-Free Nucleic Acids
87%
Circulating Neoplastic Cells
86%
Exosomes
81%
Pancreatic Neoplasms
65%
254
Scopus citations
Directional allelic imbalance profiling and visualization from multi-sample data with RECUR
Jakubek, Y. A.
,
San Lucas, F. A.
&
Scheet, P.
,
Jul 1 2019
,
In:
Bioinformatics.
35
,
13
,
p. 2300-2302
3 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Allelic Imbalance
100%
Profiling
93%
Visualization
72%
Cancer
54%
Haplotype
54%
8
Scopus citations
DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway
Adam, L.
,
San Lucas, F. A.
,
Fowler, R.
,
Yu, Y.
,
Wu, W.
,
Liu, Y.
,
Wang, H.
,
Menter, D.
,
Tetzlaff, M. T.
,
Ensor, J.
,
Manyam, G.
,
Arold, S. T.
,
Huff, C.
,
Kopetz, S.
,
Scheet, P.
&
Overman, M. J.
,
Jan 15 2019
,
In:
Clinical cancer research : an official journal of the American Association for Cancer Research.
25
,
2
,
p. 641-651
11 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
DNA Sequence Analysis
100%
Adenocarcinoma
78%
Mutation
55%
PF 00299804
51%
Exome
34%
21
Scopus citations